Cue Biopharma Reports First Quarter 2025 Financial Results and Recent Business Highlights
Provided By GlobeNewswire
Last update: May 12, 2025
Announced Boehringer Ingelheim strategic collaboration and license agreement for CUE-501, including an upfront payment of $12 million and ~$345 million in potential milestone payments
Read more at globenewswire.com0.7372
-0.01 (-1.79%)
Find more stocks in the Stock Screener
CUE Latest News and Analysis
